Puma Biotech Gets $100M Loan to Boost Breast Cancer Drug - Los Angeles Business Journal
Jobs with Puma Biotechnology
Puma Biotechnology
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology
Puma Biotechnology
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotech plunges on drug side effects
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Inc
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
PumaBiotech (@pumabiotech) / Twitter
Puma Biotechnology, Inc. | LinkedIn
PumaBiotech (@pumabiotech) / Twitter
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotech shares slide after glimpse of trial data on cancer drug | Financial Times
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Takeda farms out cancer drug alisertib to Puma Biotech -
Puma Biotechnology
